Barcelona, December 31, 2019
Bioinfogate is pleased to announce successful completion of the R&D innovation project “DEVELOPMENT OF AN ARTIFICIAL INTELLIGENCE PLATFORM TO ANTICIPATE AND MINIMIZE THE RISKS ASSOCIATED WITH THE SAFETY OF DRUGS FROM THEIR PHASE OF DISCOVERY THROUGH THEIR USE IN CLINICAL PRACTICE”.
The program has been supported by the CDTI (Center for the Development of Industrial Technology) NEOTEC initiative.
The NEOTEC program aims to support the creation and consolidation of technology-based companies (TBCs). A TBC is defined as a company that makes use of products or services that need technologies or knowledge developed from research activity. The business strategy of a TBC requires mastery of scientific and technical knowledge. The most important aspect of the proposals considered for this grant is a business strategy based on technological development (technology must be the company’s defining competitive factor) from the company’s own R&D.
Dr Josep Prous, Jr, Executive Director at Bioinfogate commented: “We are very honored to have been supported by CDTI’s NEOTEC program, and to have successfully completed the surrounding technological and business objectives. This institutional support has proven instrumental in accelerating Bioinfogate’s innovation and growth.”
Details on the specific details of CDTI’s NEOTEC program can be found here.
Bioinfogate is a forward thinking, private company working to solve unmet medical needs. Our innovative data science products support the discovery and development of better and safer drugs. We are committed to building industry-leading solutions and identifying / investing in emerging projects that align with our core business in the life sciences and data analytics.
Our passion and capabilities stem from more than 60 years of experience creating and managing biomedical knowledge, first at Prous Science (1958-2007), acquired by Thomson Reuters in 2007 (now Clarivate Analytics), and then at Prous Institute for Biomedical Research. Bioinfogate is the latest initiative within the Prous family group of companies embracing a long tradition and expertise in scientific knowledge management.
The Centre for the Development of Industrial Technology (CDTI) reports to the Ministry of Economy, Industry and Competitiveness and fosters the technological development and innovation of Spanish companies. It channels funding and support applications for national and international R&D&I projects. CDTI’s roles include financial and economic-technical assessment of R&D projects, managing and fostering participation in international technological cooperation programs, fostering international business technology transfer and supporting the set-up and consolidation of technological companies.